{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Pancreatic Cancer-Induced Diabetes: A Call To Action
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To provide information about the relationship between pancreatic cancer and diabetes.Learning Objectives
After completing this continuing education activity you will be able to:
Describe current information about research on whether new-onset diabetes mellitus (NoDM) may be an indicator of pancreatic cancer (PC).
Disclosures
The author, faculty, and staff in a position to control the content of this CME activity have disclosed that they and their spouses/life partners (if any) have no financial relationships with, or financial interests in, any commercial organizations pertaining to this educational activity.
Price:
$12.95
Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- KY-BON 1.0 CH
- GA - BON 1.0 CH
Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: OT1017
Published: Oct 2017
Expires: 12/31/2026
Sources:
Oncology Times
Required Passing Score: 7/10 (70%)
Specialties:
Oncology